News

Still suffering from an irritating cough weeks after recovering from a cold or flu? We investigated why your cough won't go ...
A phase 2a trial of camlipixant, a selective P2X3 receptor antagonist, found that while the drug did not significantly reduce ...
It’s easy to forget how deadly whooping cough, measles, rubella, and polio once were—but for families who lost loved ones, ...
Overactive bladder is a big problem as you age. Up to 30 percent of older adults experience incontinence. The problem is more prevalent in women, but the percentage of men with an overactive ...
Maple sugar and honey are natural sweeteners with different health benefits. Learn more about their nutritional values and ...
In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...
As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...
The Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), and its eight new ...
On May 6, 2025, the Global Initiative For Asthma (GINA) published the 2025 update to their Global Strategy for Asthma ...
Dr. David Rosenberg, a member of the executive board at Jewish Family Service Association of Cleveland, is known for his ...
Snag this FDA-authorized rapid test trusted by hospitals—before the next variant hitsThat Uh-Oh Feeling? Let’s Not Go There.We’ve all been there: that scratchy throat, a lingering cough, maybe a ...
Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...